Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.

Matthews E, Portaro S, Ke Q, Sud R, Haworth A, Davis MB, Griggs RC, Hanna MG.

Neurology. 2011 Nov 29;77(22):1960-4. doi: 10.1212/WNL.0b013e31823a0cb6. Epub 2011 Nov 16.

2.

SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide.

Venance SL, Jurkat-Rott K, Lehmann-Horn F, Tawil R.

Neurology. 2004 Nov 23;63(10):1977. Review. No abstract available.

PMID:
15557532
3.

[From gene to diseases; hypokalemic periodic paralysis].

Links TP, Ginjaar HB, van der Hoeven JH.

Ned Tijdschr Geneeskd. 2004 May 22;148(21):1035-8. Review. Dutch.

PMID:
15185439
4.

Treatment for periodic paralysis.

Sansone V, Meola G, Links TP, Panzeri M, Rose MR.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD005045. doi: 10.1002/14651858.CD005045.pub2. Review.

PMID:
18254068
5.

The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis.

Ke Q, He F, Lu L, Yu P, Jiang Y, Weng C, Huang H, Yi X, Qi M.

Neuromuscul Disord. 2015 Dec;25(12):955-8. doi: 10.1016/j.nmd.2015.09.006. Epub 2015 Sep 9.

PMID:
26433613
6.

New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.

Vicart S, Sternberg D, Fournier E, Ochsner F, Laforet P, Kuntzer T, Eymard B, Hainque B, Fontaine B.

Neurology. 2004 Dec 14;63(11):2120-7.

PMID:
15596759
7.

Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.

Wu F, Mi W, Cannon SC.

Brain. 2013 Dec;136(Pt 12):3766-74. doi: 10.1093/brain/awt280. Epub 2013 Oct 18.

8.

Genotype and phenotype analysis of patients with sporadic periodic paralysis.

Sung CC, Cheng CJ, Lo YF, Lin MS, Yang SS, Hsu YC, Lin SH.

Am J Med Sci. 2012 Apr;343(4):281-5. doi: 10.1097/MAJ.0b013e31822b430c.

PMID:
21841462
9.

Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis.

Wang XY, Ren BW, Yong ZH, Xu HY, Fu QX, Yao HB.

Mol Med Rep. 2015 Oct;12(4):6267-74. doi: 10.3892/mmr.2015.4201. Epub 2015 Aug 7.

PMID:
26252573
10.

Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis.

Bendahhou S, Cummins TR, Griggs RC, Fu YH, Ptácek LJ.

Ann Neurol. 2001 Sep;50(3):417-20.

PMID:
11558801
12.

Mutations of SCN4A gene cause different diseases: 2 case reports and literature review.

Liu XL, Huang XJ, Luan XH, Zhou HY, Wang T, Wang JY, Chen SD, Tang HD, Cao L.

Channels (Austin). 2015;9(2):82-7. doi: 10.1080/19336950.2015.1012945. Review.

13.

[A case of hypokalemic periodic paralysis: utility of exercise test for the assessment of therapeutic efficacy].

Watanabe M, Hasegawa T, Takeda A, Shiga Y, Itoyama Y.

No To Shinkei. 2003 Jun;55(6):527-9. Japanese.

PMID:
12884806
14.

Acute hypokalemic periodic paralysis possibly precipitated by albuterol.

Tucker C, Villanueva L.

Am J Health Syst Pharm. 2013 Sep 15;70(18):1588-91. doi: 10.2146/ajhp130086.

PMID:
23988599
15.

The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis.

Kim JB, Kim MH, Lee SJ, Kim DJ, Lee BC.

J Korean Med Sci. 2007 Dec;22(6):946-51.

16.

[R1239H mutation of CACNA1S gene in a Chinese family with hypokalaemic periodic paralysis].

Ke Q, Wu WP, Guo XH, Xu QG, Huang DH, Mao YL, Huo CN.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Jun;23(3):272-4. Chinese.

PMID:
16767662
17.
18.

Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?

Matthews E, Hanna MG.

J Physiol. 2010 Jun 1;588(Pt 11):1879-86. doi: 10.1113/jphysiol.2009.186627. Epub 2010 Feb 1. Review.

19.

Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels.

Tricarico D, Mele A, Conte Camerino D.

Neuromuscul Disord. 2006 Jan;16(1):39-45. Epub 2005 Dec 20.

PMID:
16368240
20.

Gastro-enteritis in hypokalemic periodic paralysis: a life threatening condition.

Ebus S, Verrips A, Ginjaar IB, Verhagen WI.

Clin Neurol Neurosurg. 2012 Jul;114(6):801-2. doi: 10.1016/j.clineuro.2011.12.046. Epub 2012 Feb 5. No abstract available.

PMID:
22311001

Supplemental Content

Support Center